Table of Content

1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Overview
1.1 Product Overview and Scope of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
1.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Type
1.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Type (2024-2034)
1.2.2 Dominant Optic Atrophy
1.2.3 Recessive Optic Atrophy
1.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Application
1.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Medical Research Institute
1.3.5 Other
1.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Estimates and Forecasts
1.4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2024-2034
1.4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2024-2034
1.4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competition by Manufacturers
2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2024-2024)
2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price by Manufacturers (2024-2024)
2.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Type & Application
2.7 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competitive Situation and Trends
2.7.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players Market Share by Revenue
2.7.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Retrospective Market Scenario by Region
3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2024-2034
3.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2024-2024
3.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2024-2034
3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2024-2034
3.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2024-2024
3.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2024-2034
3.4 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.4.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034)
3.4.3 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.5.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034)
3.5.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.6.1 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034)
3.6.3 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.7.1 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034)
3.7.3 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country
3.8.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034)
3.8.3 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2034)
4.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2024)
4.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2024-2034)
4.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2024-2034)
4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2024-2034)
4.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2024-2024)
4.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2024-2034)
4.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2024-2034)
4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2024-2034)
5 Segment by Application
5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2034)
5.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2024)
5.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2024-2034)
5.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2024-2034)
5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2024-2034)
5.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2024-2024)
5.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2024-2034)
5.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2024-2034)
5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Alkeus Pharmaceuticals
6.1.1 Alkeus Pharmaceuticals Corporation Information
6.1.2 Alkeus Pharmaceuticals Description and Business Overview
6.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.1.5 Alkeus Pharmaceuticals Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Biovista
6.3.1 Biovista Corporation Information
6.3.2 Biovista Description and Business Overview
6.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.3.5 Biovista Recent Developments/Updates
6.4 Editas Medicine
6.4.1 Editas Medicine Corporation Information
6.4.2 Editas Medicine Description and Business Overview
6.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.4.5 Editas Medicine Recent Developments/Updates
6.5 GenSight Biologics
6.5.1 GenSight Biologics Corporation Information
6.5.2 GenSight Biologics Description and Business Overview
6.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.5.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.5.5 GenSight Biologics Recent Developments/Updates
6.6 Ixchel Pharma
6.6.1 Ixchel Pharma Corporation Information
6.6.2 Ixchel Pharma Description and Business Overview
6.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.6.5 Ixchel Pharma Recent Developments/Updates
6.7 Khondrion
6.6.1 Khondrion Corporation Information
6.6.2 Khondrion Description and Business Overview
6.6.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.7.5 Khondrion Recent Developments/Updates
6.8 Mitotech
6.8.1 Mitotech Corporation Information
6.8.2 Mitotech Description and Business Overview
6.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.8.5 Mitotech Recent Developments/Updates
6.9 ProQR Therapeutics
6.9.1 ProQR Therapeutics Corporation Information
6.9.2 ProQR Therapeutics Description and Business Overview
6.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.9.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.9.5 ProQR Therapeutics Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Spark Therapeutics
6.11.1 Spark Therapeutics Corporation Information
6.11.2 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview
6.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.11.5 Spark Therapeutics Recent Developments/Updates
6.12 Stealth BioTherapeutics
6.12.1 Stealth BioTherapeutics Corporation Information
6.12.2 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview
6.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.12.5 Stealth BioTherapeutics Recent Developments/Updates
6.13 Usher Syndrome
6.13.1 Usher Syndrome Corporation Information
6.13.2 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview
6.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio
6.13.5 Usher Syndrome Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Chain Analysis
7.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process
7.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Marketing
7.4.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Channels
7.4.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
7.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers
8 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Dynamics
8.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends
8.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
8.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
8.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) of Key Manufacturers (2024-2024)
Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price (USD/Piece) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Type & Application
Table 12. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2024) & (K Pcs)
Table 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2024-2024)
Table 19. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2024-2034)
Table 21. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2024-2024)
Table 23. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2024-2034)
Table 25. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (K Pcs)
Table 27. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (K Pcs)
Table 32. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2024) & (K Pcs)
Table 37. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (K Pcs)
Table 42. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2024) & (K Pcs)
Table 47. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Type (2024-2024)
Table 51. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Type (2024-2034)
Table 52. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2024-2024)
Table 53. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2024-2034)
Table 54. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2024-2024)
Table 57. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2024-2034)
Table 58. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Type (2024-2024)
Table 59. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Type (2024-2034)
Table 60. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Application (2024-2024)
Table 61. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Application (2024-2034)
Table 62. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2024-2024)
Table 63. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2024-2034)
Table 64. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2024-2024)
Table 67. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2024-2034)
Table 68. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Application (2024-2024)
Table 69. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Application (2024-2034)
Table 70. Alkeus Pharmaceuticals Corporation Information
Table 71. Alkeus Pharmaceuticals Description and Business Overview
Table 72. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 73. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 74. Alkeus Pharmaceuticals Recent Developments/Updates
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 78. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 79. Amgen Recent Developments/Updates
Table 80. Biovista Corporation Information
Table 81. Biovista Description and Business Overview
Table 82. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 83. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 84. Biovista Recent Developments/Updates
Table 85. Editas Medicine Corporation Information
Table 86. Editas Medicine Description and Business Overview
Table 87. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 88. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 89. Editas Medicine Recent Developments/Updates
Table 90. GenSight Biologics Corporation Information
Table 91. GenSight Biologics Description and Business Overview
Table 92. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 93. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 94. GenSight Biologics Recent Developments/Updates
Table 95. Ixchel Pharma Corporation Information
Table 96. Ixchel Pharma Description and Business Overview
Table 97. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 98. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 99. Ixchel Pharma Recent Developments/Updates
Table 100. Khondrion Corporation Information
Table 101. Khondrion Description and Business Overview
Table 102. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 103. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 104. Khondrion Recent Developments/Updates
Table 105. Mitotech Corporation Information
Table 106. Mitotech Description and Business Overview
Table 107. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 108. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 109. Mitotech Recent Developments/Updates
Table 110. ProQR Therapeutics Corporation Information
Table 111. ProQR Therapeutics Description and Business Overview
Table 112. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 113. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 114. ProQR Therapeutics Recent Developments/Updates
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 118. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Spark Therapeutics Corporation Information
Table 121. Spark Therapeutics Description and Business Overview
Table 122. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 123. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 124. Spark Therapeutics Recent Developments/Updates
Table 125. Stealth BioTherapeutics Corporation Information
Table 126. Stealth BioTherapeutics Description and Business Overview
Table 127. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 128. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 129. Stealth BioTherapeutics Recent Developments/Updates
Table 130. Usher Syndrome Corporation Information
Table 131. Usher Syndrome Description and Business Overview
Table 132. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2024-2024)
Table 133. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
Table 134. Usher Syndrome Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
Table 138. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List
Table 139. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Trends
Table 140. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
Table 141. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
Table 142. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Figure 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type in 2022 & 2034
Figure 4. Dominant Optic Atrophy Product Picture
Figure 5. Recessive Optic Atrophy Product Picture
Figure 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application in 2022 & 2034
Figure 8. Hospitals
Figure 9. Eye Clinics
Figure 10. Medical Research Institute
Figure 11. Other
Figure 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size (2024-2034) & (US$ Million)
Figure 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2024-2034) & (K Pcs)
Figure 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price (USD/Piece) & (2024-2034)
Figure 16. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Report Years Considered
Figure 17. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Manufacturers in 2022
Figure 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players: Market Share by Revenue in 2022
Figure 20. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 21. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 22. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2024-2034)
Figure 23. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2024-2034)
Figure 24. U.S. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2024-2034)
Figure 27. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2024-2034)
Figure 28. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2024-2034)
Figure 34. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2024-2034)
Figure 35. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Australia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Indonesia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Thailand Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Malaysia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Philippines Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2024-2034)
Figure 46. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2024-2034)
Figure 47. Mexico Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Brazil Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Argentina Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2024-2034)
Figure 51. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2024-2034)
Figure 52. Turkey Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. U.A.E Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type (2024-2034)
Figure 56. Global Revenue Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type (2024-2034)
Figure 57. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Type (2024-2034)
Figure 58. Global Sales Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2024-2034)
Figure 59. Global Revenue Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2024-2034)
Figure 60. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Application (2024-2034)
Figure 61. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Value Chain
Figure 62. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed